Showing results (301-310 of 317) with videos related to

Sort By:
Pageof 32
Blood|January 20, 2022
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemiaCavan Bennett, Moyra Lawrence, Jose A Guerrero, et al.
The New England Journal of Medicine|December 22, 2021
Multicomponent Strategy with Decentralized Molecular Testing for TuberculosisAdithya Cattamanchi, Tania F Reza, Talemwa Nalugwa, et al.
The Journal of Infection|May 19, 2022
Diagnostic accuracy of WHO screening criteria to guide lateral-flow lipoarabinomannan testing among HIV-positive inpatients: A systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
The Lancet. Global Health|January 31, 2025
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluationSedona Sweeney, Yoko V Laurence, Catherine Berry, et al.
Plos Medicine|September 7, 2021
Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort studyAndrew F Auld, Andrew D Kerkhoff, Yasmeen Hanifa, et al.
BMC Medicine|November 9, 2020
Risk scores for predicting early antiretroviral therapy mortality in sub-Saharan Africa to inform who needs intensification of care: a derivation and external validation cohort studyAndrew F Auld, Katherine Fielding, Tefera Agizew, et al.
Lancet (London, England)|March 14, 2025
Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trialsDegu Jerene, Kristian van Kalmthout, Jens Levy, et al.
The Lancet. HIV|February 9, 2026
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trialJayne Ellis, Gila Hale, Laura J Nsangi, et al.
The Lancet. Global Health|January 27, 2019
Effect of Xpert MTB/RIF on clinical outcomes in routine care settings: individual patient data meta-analysisGian Luca Di Tanna, Ali Raza Khaki, Grant Theron, et al.
The Lancet. HIV|March 26, 2022
Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysisAshar Dhana, Yohhei Hamada, Andre P Kengne, et al.
Pageof 32